Aristotle Capital Boston’s Hexcel HXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9M Sell
209,350
-41,809
-17% -$3.79M 1.41% 18
2026
Q1
$20.4M Sell
251,159
-39,496
-14% -$3.33M 1.26% 21
2025
Q4
$21.5M Buy
290,655
+29,249
+11% +$2.07M 1.18% 26
2025
Q3
$16.4M Sell
261,406
-784
-0.3% -$48.1K 0.84% 51
2025
Q2
$14.8M Buy
262,190
+45,889
+21% +$2.43M 0.75% 57
2025
Q1
$11.8M Sell
216,301
-20,437
-9% -$1.28M 0.59% 68
2024
Q4
$14.8M Buy
+236,738
New +$14.6M 0.55% 73

Other funds holding HXL

Aristotle Capital Boston's HXL Position: Q2 2026 in Review

Aristotle Capital Boston reduced its Hexcel (HXL) stake by 17% in Q2 2026, selling an estimated $3.79M and leaving 209,350 shares worth $20.9M. The position accounts for 1.41% of the portfolio, ranked #18.

Aristotle Capital Boston first reported a position in HXL in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.5M in Q4 2025. 530 funds tracked by Wall St. Rank hold HXL as of Q2 2026.

  • Aristotle Capital Boston held 209,350 shares of Hexcel worth $20.9M as of Q2 2026.
  • Aristotle Capital Boston sold 41,809 Hexcel shares in Q2 2026, an estimated $3.79M.
  • Hexcel made up 1.41% of Aristotle Capital Boston's portfolio in Q2 2026, its #18 holding.
  • Aristotle Capital Boston first reported a position in Hexcel in Q4 2024 and has held it in 7 quarters since.
  • Aristotle Capital Boston's Hexcel position peaked at $21.5M in Q4 2025.
  • 530 funds tracked by Wall St. Rank held Hexcel as of Q2 2026.

Based on Aristotle Capital Boston's 13F filing for Q2 2026, filed 14 Aug 2026.